Pathways To Access & Reimbursement

Andrea Masters

Director, Strategic Access and Pricing Lead

Roche

Rebecca Vieira

Head of Access and Pricing

Vertex Pharmaceuticals

Gail Attara

Chief Executive Officer

Gastrointestinal Society

Stephane Barakat

Head, Market Access & HEOR – Oncology

AbbVie

Mélanie Caron

Director, Evaluation of Medicines and Technologies for Reimbursement Purposes

INESSS

Alex Chambers

Senior Market Access Manager

Bayer

Rosemarie Childerhose

Head of Market Access & Pricing

Biocon Biologics

Tara Cowling

President

Medlior

Ed Dybka

General Manager

Ipsen Canada

Jason Field

President & CEO

Life Sciences Ontario

Julie Frappier

President & Founder

TOWWERS Program, Data4Actions

Elena Georgieva

Associate Principal

IQVIA

David Greiss

Director of Pharmaceutical Partnerships and Operations

GreenShield

Bettina Hamelin

President

Innovative Medicines Canada (IMC)

Gerry Jeffcott

Senior Associate

3Sixty Public Affairs

Farah Jivraj

Head of Market Access, Policy and Stakeholder Relations

Biogen

Dara Jospé

Partner

Fasken

Sudha Kutty

Executive Vice-President, Evidence, Products, and Services

Canada's Drug Agency

Stephanie Landon

Senior Healthcare Communications Specialist

Philippe Laplante, FICA,FSA

Principal

Eckler

Suzanne Lepage

Private Health Plan Strategist

Suzanne Lepage Consulting

Ursula Mann

Principal and Chief Patient Officer (CPO)

PatientVoicePartners

Farah Meghji

Co-Founder

Unum Co.

Sang Mi Lee

Executive Director

Morse Consulting Inc.

Michael Nashat, PharmD, RPh

Director

OnPharm-United

Mark Omoto

General Manager

IQVIA

Gail Ouellette

Director

Canadian iRARE Centres

Nathan Sigworth

President and Founder

CCX

Claire Snyman

Patient Experience Consultant

Robby Spring

Health Innovation, Patient Engagement and Advocacy

Mina Tadrous

Assistant Professor
Leslie Dan Faculty of Pharmacy

University of Toronto

Durhane Wong-Rieger

President & CEO

CORD